{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:10:42Z","timestamp":1792800642380,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran","award":["1403-2-221-73074"],"award-info":[{"award-number":["1403-2-221-73074"]}],"id":[{"id":"https:\/\/ror.org\/01c4pz451","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02660-0","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T03:03:20Z","timestamp":1751857400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of dyslipidemia and its association with blood pressure control in Iranian hypertensive patients: insights from STEPS 2021"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3579-8898","authenticated-orcid":false,"given":"Shervin","family":"Mossavarali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3875-3871","authenticated-orcid":false,"given":"Yosra","family":"Azizpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5192-0435","authenticated-orcid":false,"given":"Ali","family":"Golestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-1783","authenticated-orcid":false,"given":"Nazila","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-0787","authenticated-orcid":false,"given":"Sepehr","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0634-3293","authenticated-orcid":false,"given":"Mina","family":"Mirzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0736-2181","authenticated-orcid":false,"given":"Pouria","family":"Khashayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0188-9721","authenticated-orcid":false,"given":"Ozra","family":"Tabatabaei-Malazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"2660_CR1","unstructured":"Pappan NAA, Rehman A. Dyslipidemia StatPearls. Treasure Island (FL) [updated 2024 Mar 4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560891\/"},{"issue":"12","key":"2660_CR2","doi-asserted-by":"publisher","first-page":"e049662","DOI":"10.1136\/bmjopen-2021-049662","volume":"11","author":"MS Mohamed-Yassin","year":"2021","unstructured":"Mohamed-Yassin MS, Baharudin N, Abdul-Razak S, Ramli AS, Lai NM. Global prevalence of dyslipidaemia in adult populations: a systematic review protocol. BMJ Open. 2021;11(12):e049662.","journal-title":"BMJ Open"},{"issue":"10304","key":"2660_CR3","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"Worldwide trends in","year":"2021","unstructured":"Worldwide trends in. Hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"3","key":"2660_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.26719\/emhj.19.042","volume":"26","author":"M Katibeh","year":"2020","unstructured":"Katibeh M, Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J. 2020;26(3):304\u201314.","journal-title":"East Mediterr Health J"},{"issue":"6","key":"2660_CR5","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1007\/s12325-019-00941-6","volume":"36","author":"F Spannella","year":"2019","unstructured":"Spannella F, Giulietti F, Di Pentima C, Sarzani R. Prevalence and control of dyslipidemia in patients referred for high blood pressure: the disregarded double-trouble lipid profile in overweight\/obese. Adv Ther. 2019;36(6):1426\u201337.","journal-title":"Adv Ther"},{"issue":"4","key":"2660_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone MA Jr., Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620\u201336.","journal-title":"Circ Res"},{"key":"2660_CR7","doi-asserted-by":"crossref","unstructured":"Katsi V, Vamvakou G, Makris T, Kallikazaros I, Tousoulis D. [PP.30.22] Dyslipidemia and aggravated quality of life in hypertensives. J Hypertens. 2016;34.","DOI":"10.1097\/01.hjh.0000492257.18909.03"},{"issue":"1","key":"2660_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12872-022-02491-2","volume":"22","author":"C Wang","year":"2022","unstructured":"Wang C, Du Z, Ye N, Shi C, Liu S, Geng D, et al. Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China. BMC Cardiovasc Disord. 2022;22(1):47.","journal-title":"BMC Cardiovasc Disord"},{"key":"2660_CR9","doi-asserted-by":"crossref","unstructured":"Hadaegh A, Akbarpour S, Tohidi M, Barzegar N, Hosseinpour-Niazi S, Azizi F et al. The role of different lipid measures for incident hypertension during more than 12-year follow-up: Tehran lipid and glucose study. Br J Nutr. 2022;128(9):1700\u201310.","DOI":"10.1017\/S0007114521004657"},{"issue":"3","key":"2660_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s40292-022-00507-8","volume":"29","author":"C Borghi","year":"2022","unstructured":"Borghi C, Fogacci F, Agnoletti D, Cicero AFG. Hypertension and dyslipidemia combined therapeutic approaches. High Blood Press Cardiovasc Prev. 2022;29(3):221\u201330.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2660_CR11","doi-asserted-by":"publisher","first-page":"1721727X2211444","DOI":"10.1177\/1721727X221144454","volume":"21","author":"J Wan","year":"2023","unstructured":"Wan J, Chen M. Effects of statin on hypertension patients: a systematic review and meta-analysis. Eur J Inflamm. 2023;21:1721727X221144454.","journal-title":"Eur J Inflamm"},{"key":"2660_CR12","doi-asserted-by":"crossref","unstructured":"Abebe RB, Kebede SA, Birarra MK. The association of lipid-lowering therapy and blood pressure control among outpatients with hypertension at the Felege Hiwot comprehensive specialized hospital, Northwest Ethiopia. Front Cardiovasc Med. 2023;10.","DOI":"10.3389\/fcvm.2023.1071338"},{"key":"2660_CR13","doi-asserted-by":"publisher","first-page":"102034","DOI":"10.1016\/j.eclinm.2023.102034","volume":"60","author":"A Mansouri","year":"2023","unstructured":"Mansouri A, Khosravi A, Mehrabani-Zeinabad K, Kopec JA, Adawi KII, Lui M, et al. Trends in the burden and determinants of hypertensive heart disease in the Eastern mediterranean region, 1990\u20132019: an analysis of the global burden of disease study 2019. EClinicalMedicine. 2023;60:102034.","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2660_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S2213-8587(19)30179-2","volume":"7","author":"F Azizi","year":"2019","unstructured":"Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, et al. Metabolic health in the middle East and North Africa. Lancet Diabetes Endocrinol. 2019;7(11):866\u201379.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"2660_CR15","first-page":"607","volume":"14","author":"S Mohammadi","year":"2023","unstructured":"Mohammadi S, Hassanipour S, Delam H, Nikbakht HA, Ghaem Far Z, Firoozi D, et al. Prevalence of hypertension in iran: an updated systematic review and meta-analysis of community-based studies. Casp J Intern Med. 2023;14(4):607\u201317.","journal-title":"Casp J Intern Med"},{"issue":"1","key":"2660_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5334\/gh.1120","volume":"17","author":"A Oraii","year":"2022","unstructured":"Oraii A, Shafiee A, Jalali A, Alaeddini F, Saadat S, Sadeghian S, et al. Prevalence, awareness, treatment, and control of hypertension among adult residents of tehran: the Tehran cohort study. Glob Heart. 2022;17(1):31.","journal-title":"Glob Heart"},{"issue":"9","key":"2660_CR17","first-page":"608","volume":"20","author":"S Djalalinia","year":"2017","unstructured":"Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol design for large-scale cross-sectional studies of surveillance of risk factors of non-communicable diseases in iran: steps 2016. Arch Iran Med. 2017;20(9):608\u201316.","journal-title":"Arch Iran Med"},{"key":"2660_CR18","unstructured":"WHO. Manual STEPS. 2021 [Available from: https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps\/manuals"},{"issue":"9","key":"2660_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.34172\/aim.2022.99","volume":"25","author":"S Djalalinia","year":"2022","unstructured":"Djalalinia S, Azadnajafabad S, Ghasemi E, Yoosefi M, Rezaei N, Farzi Y, et al. Protocol design for surveillance of risk factors of non-communicable diseases during the COVID-19 pandemic: an experience from Iran STEPS survey 2021. Arch Iran Med. 2022;25(9):634\u201346.","journal-title":"Arch Iran Med"},{"issue":"17","key":"2660_CR20","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1161\/CIRCULATIONAHA.120.048996","volume":"143","author":"DD Wang","year":"2021","unstructured":"Wang DD, Li Y, Bhupathiraju SN, Rosner BA, Sun Q, Giovannucci EL, et al. Fruit and vegetable intake and mortality. Circulation. 2021;143(17):1642\u201354.","journal-title":"Circulation"},{"key":"2660_CR21","unstructured":"WHO. Global Physical Activity Questionnaire (GPAQ) Analysis Guide 2021 [Available from: https:\/\/www.who.int\/docs\/default-source\/ncds\/ncd-surveillance\/gpaq-analysis-guide.pdf"},{"key":"2660_CR22","unstructured":"Weir CBJA. BMI classification percentile and cut off points: StatPearls; 2024 Jan [updated 2023 Jun 26. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/"},{"issue":"3","key":"2660_CR23","first-page":"243","volume":"13","author":"F Azizi","year":"2010","unstructured":"Azizi F, Khalili D, Aghajani H, Esteghamati A, Hosseinpanah F, Delavari A, et al. Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(3):243\u20134.","journal-title":"Arch Iran Med"},{"key":"2660_CR24","unstructured":"Ministry of Health and Medical Education N-CDMO. Essential interventions for non-communicable diseases in primary health care in iran (IraPEN). Iran; 2017."},{"issue":"5","key":"2660_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"key":"2660_CR26","doi-asserted-by":"crossref","unstructured":"KDIGO. 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4s):S117-s314.","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"Supplement1","key":"2660_CR27","first-page":"S20","volume":"47","author":"American Diabetes Association Professional Practice C. 2","year":"2023","unstructured":"American Diabetes Association Professional Practice C. 2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024. Diabetes Care. 2023;47(Supplement1):S20\u201342.","journal-title":"Diabetes Care"},{"issue":"4","key":"2660_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjcard.2005.06.006","volume":"96","author":"NJ Stone","year":"2005","unstructured":"Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III update: adjustments and options. Am J Cardiol. 2005;96(4):53\u20139.","journal-title":"Am J Cardiol"},{"issue":"7","key":"2660_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/oem.2007.034777","volume":"65","author":"JA Deddens","year":"2008","unstructured":"Deddens JA, Petersen MR. Approaches for estimating prevalence ratios. Occup Environ Med. 2008;65(7):481.","journal-title":"Occup Environ Med"},{"issue":"3","key":"2660_CR30","first-page":"120","volume":"2","author":"G Ghooshchi","year":"2014","unstructured":"Ghooshchi G, Masoomian M, Sarafraz Yazdi M, Pour Ramezan M. Evaluation of the lipid profile of hypertensive patients compared to non- hypertensive individuals. J Patient Saf Qual Improv. 2014;2(3):120\u20132.","journal-title":"J Patient Saf Qual Improv"},{"issue":"12","key":"2660_CR31","doi-asserted-by":"publisher","first-page":"e0295270","DOI":"10.1371\/journal.pone.0295270","volume":"18","author":"MG Zare","year":"2023","unstructured":"Zare MG, Okati-Aliabad H, Ansari-Moghaddam A, Mohammadi M, Shahraki-Sanavi F. Prevalence and risk factors of pre-hypertension and hypertension among adults in southeastern iran: findings from the baseline survey of the Zahedan adult cohort study. PLoS ONE. 2023;18(12):e0295270.","journal-title":"PLoS ONE"},{"issue":"6","key":"2660_CR32","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.arcmed.2005.12.005","volume":"37","author":"R Yin","year":"2006","unstructured":"Yin R, Chen Y, Pan S, He F, Liu T, Yang D, et al. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res. 2006;37(6):787\u201393.","journal-title":"Arch Med Res"},{"issue":"6","key":"2660_CR33","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jacl.2018.08.001","volume":"12","author":"Z Aryan","year":"2018","unstructured":"Aryan Z, Mahmoudi N, Sheidaei A, Rezaei S, Mahmoudi Z, Gohari K, et al. The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: surveillance of risk factors of noncommunicable diseases in Iran 2016. J Clin Lipidol. 2018;12(6):1471\u2013e814.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"2660_CR34","doi-asserted-by":"publisher","first-page":"15499","DOI":"10.1038\/s41598-023-42341-5","volume":"13","author":"J Khanali","year":"2023","unstructured":"Khanali J, Ghasemi E, Rashidi M-M, Ahmadi N, Ghamari S-H, Azangou-Khyavy M, et al. Prevalence of plasma lipid abnormalities and associated risk factors among Iranian adults based on the findings from steps survey 2021. Sci Rep. 2023;13(1):15499.","journal-title":"Sci Rep"},{"issue":"2","key":"2660_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.34172\/aim.2024.10","volume":"27","author":"A Shafiee","year":"2024","unstructured":"Shafiee A, Kazemian S, Jalali A, Alaeddini F, Saadat S, Masoudkabir F, et al. Epidemiology and prevalence of dyslipidemia among adult population of tehran: the Tehran cohort study. Arch Iran Med. 2024;27(2):51\u201361.","journal-title":"Arch Iran Med"},{"key":"2660_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000509570","volume":"3","author":"OG Ayoade","year":"2020","unstructured":"Ayoade OG, Umoh IO, Amadi C. Dyslipidemia and associated risk factors among Nigerians with hypertension. Dubai Med J. 2020;3:155\u201361.","journal-title":"Dubai Med J"},{"issue":"3","key":"2660_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ancard.2018.04.015","volume":"67","author":"A Bachir Cherif","year":"2018","unstructured":"Bachir Cherif A, Bennouar S, Bouamra A, Taleb A, Hamida F, Temmar M, et al. Prevalence of diabetes and dyslipidemia in hypertensive patients in the area of blida (Algeria). Ann Cardiol Angeiol (Paris). 2018;67(3):198\u2013203.","journal-title":"Ann Cardiol Angeiol (Paris)"},{"issue":"3","key":"2660_CR38","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4103\/jpbs.JPBS_82_19","volume":"11","author":"OA Nassr","year":"2019","unstructured":"Nassr OA, Forsyth P. Evaluation of blood pressure control and associated factors among patients with hypertension in iraq: a prospective cross-sectional study. J Pharm Bioallied Sci. 2019;11(3):232\u20139.","journal-title":"J Pharm Bioallied Sci"},{"key":"2660_CR39","doi-asserted-by":"crossref","unstructured":"Gupta P, Chaurasia A, Mishra A, Prakash G. Study of prevalence of dyslipidemia in newly diagnosed essential hypertension. Int J Contemp Med Surg Radiol. 2018;3.","DOI":"10.21276\/ijcmsr.2018.3.4.22"},{"issue":"1","key":"2660_CR40","first-page":"195","volume":"7","author":"SN Rehman Khalil","year":"2022","unstructured":"Rehman Khalil SN, Naresh Kumar. Gender difference in lipid profile in hypertensive patients hospital-based study. Cardio Open. 2022;7(1):195\u20139.","journal-title":"Cardio Open"},{"issue":"5","key":"2660_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/jch.13268","volume":"20","author":"M Cherfan","year":"2018","unstructured":"Cherfan M, Blacher J, Asmar R, Chahine MN, Zeidan RK, Farah R, et al. Prevalence and risk factors of hypertension: a nationwide cross-sectional study in Lebanon. J Clin Hypertens (Greenwich). 2018;20(5):867\u201379.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2660_CR42","doi-asserted-by":"publisher","first-page":"3210617","DOI":"10.1155\/2019\/3210617","volume":"2019","author":"Y Khader","year":"2019","unstructured":"Khader Y, Batieha A, Jaddou H, Rawashdeh SI, El-Khateeb M, Hyassat D, et al. Hypertension in jordan: prevalence, awareness, control, and its associated factors. Int J Hypertens. 2019;2019:3210617.","journal-title":"Int J Hypertens"},{"key":"2660_CR43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1186\/s12889-015-2486-7","volume":"15","author":"S Yu","year":"2015","unstructured":"Yu S, Yang H, Guo X, Zhang X, Zheng L, Sun Y. Prevalence of dyslipidemia and associated factors among the hypertensive population from rural Northeast China. BMC Public Health. 2015;15:1152.","journal-title":"BMC Public Health"},{"key":"2660_CR44","doi-asserted-by":"publisher","first-page":"100108","DOI":"10.1016\/j.metop.2021.100108","volume":"11","author":"ZD Kifle","year":"2021","unstructured":"Kifle ZD, Alehegn AA, Adugna M, Bayleyegn B. Prevalence and predictors of dyslipidemia among hypertensive patients in lumame primary hospital, amhara, ethiopia: a cross-sectional study. Metabol Open. 2021;11:100108.","journal-title":"Metabol Open"},{"issue":"1","key":"2660_CR45","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/sjo.SJO_3_22","volume":"7","author":"IA Azeez","year":"2019","unstructured":"Azeez IA, Olubayo AM, Adeyemo KA. Prevalence and predictors of dyslipidemia among hypertensive patients attending a secondary healthcare center in Southwestern Nigeria. Saudi J Obes. 2019;7(1):21\u20138.","journal-title":"Saudi J Obes"},{"key":"2660_CR46","doi-asserted-by":"crossref","unstructured":"Wang L, Yan N, Zhang M, Pan R, Dang Y, Niu Y. The association between blood glucose levels and lipids or lipid ratios in type 2 diabetes patients: a cross-sectional study. Front Endocrinol. 2022;13.","DOI":"10.3389\/fendo.2022.969080"},{"key":"2660_CR47","unstructured":"Herink MIM. Medication induced changes in lipid and lipoproteins South Dartmouth (MA): MDText.com, Inc.; 2018 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326739\/"},{"issue":"1","key":"2660_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/jch.13139","volume":"20","author":"FF Costa Filho","year":"2018","unstructured":"Costa Filho FF, Timerman A, Saraiva JFK, Magalhaes CC, Pinto IMF, Oliveira GBF, et al. Independent predictors of effective blood pressure control in patients with hypertension on drug treatment in Brazil. J Clin Hypertens (Greenwich). 2018;20(1):125\u201332.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"2660_CR49","first-page":"e59036","volume":"16","author":"MM Hirani","year":"2024","unstructured":"Hirani MM, Gandhi R, Thakkar DG, Kateshiya N, Murugan Y. Investigating the prevalence and predictors of uncontrolled hypertension: a cross-sectional study in Gujarat, India. Cureus. 2024;16(4):e59036.","journal-title":"Cureus"},{"key":"2660_CR50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/JMDH.S156518","volume":"11","author":"S Visanuyothin","year":"2018","unstructured":"Visanuyothin S, Plianbangchang S, Somrongthong R. Appearance and potential predictors of poorly controlled hypertension at the primary care level in an urban community. J Multidiscip Healthc. 2018;11:131\u20138.","journal-title":"J Multidiscip Healthc"},{"key":"2660_CR51","doi-asserted-by":"crossref","unstructured":"Makukule A, Modjadji P, Thovhogi N, Mokgalaboni K, Kengne AP. Uncontrolled hypertension, treatment, and predictors among hypertensive out-patients attending primary health facilities in Johannesburg, South Africa. Healthc (Basel). 2023;11(20).","DOI":"10.3390\/healthcare11202783"},{"issue":"1","key":"2660_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s13104-017-2971-4","volume":"10","author":"L Jahangiry","year":"2017","unstructured":"Jahangiry L, Ghanbari J, Abbasalizad Farhangi M, Sarbakhsh P, Ponnet K. Predictors of poor blood pressure control among Iranian hypertensive patients. BMC Res Notes. 2017;10(1):668.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2660_CR53","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12872-023-03357-x","volume":"23","author":"F Farhadi","year":"2023","unstructured":"Farhadi F, Aliyari R, Ebrahimi H, Hashemi H, Emamian MH, Fotouhi A. Prevalence of uncontrolled hypertension and its associated factors in 50\u201374 years old Iranian adults: a population-based study. BMC Cardiovasc Disord. 2023;23(1):318.","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"2660_CR54","first-page":"6790","volume":"5","author":"JH Sung","year":"2018","unstructured":"Sung JH, Lee JE, Lee JY. Biomarker differences between controlled and uncontrolled hypertension among US Adults: National Health and Nutrition Examination Survey 2005\u20132010. Int J Adv Res Sci Eng Technol. 2018;5(9):6790\u20137.","journal-title":"Int J Adv Res Sci Eng Technol"},{"issue":"11","key":"2660_CR55","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/ajh\/hpy071","volume":"31","author":"TH Jafar","year":"2018","unstructured":"Jafar TH, Gandhi M, Jehan I, Naheed A, de Silva HA, Shahab H, et al. Determinants of uncontrolled hypertension in rural communities in South Asia-Bangladesh, Pakistan, and Sri Lanka. Am J Hypertens. 2018;31(11):1205\u201314.","journal-title":"Am J Hypertens"},{"issue":"9","key":"2660_CR56","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/jch.14352","volume":"23","author":"S Rabizadeh","year":"2021","unstructured":"Rabizadeh S, Gholami B, Mahmoudzadeh Kani S, Rajab A, Farrokhpour H, Esteghamati A, et al. Uncontrolled hypertension in patients with type 2 diabetes: what are the correlates? J Clin Hypertens (Greenwich). 2021;23(9):1776\u201385.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"2660_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11892-019-1136-3","volume":"19","author":"AS Alexopoulos","year":"2019","unstructured":"Alexopoulos AS, Qamar A, Hutchins K, Crowley MJ, Batch BC, Guyton JR. Triglycerides: emerging targets in diabetes care?? Review of moderate hypertriglyceridemia in diabetes. Curr Diab Rep. 2019;19(4):13.","journal-title":"Curr Diab Rep"},{"key":"2660_CR58","doi-asserted-by":"publisher","first-page":"117270","DOI":"10.1016\/j.atherosclerosis.2023.117270","volume":"384","author":"KB Holven","year":"2023","unstructured":"Holven KB, van Roeters J. Sex differences in lipids: a life course approach. Atherosclerosis. 2023;384:117270.","journal-title":"Atherosclerosis"},{"issue":"11","key":"2660_CR59","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/GME.0000000000001403","volume":"26","author":"A Ambikairajah","year":"2019","unstructured":"Ambikairajah A, Walsh E, Cherbuin N. Lipid profile differences during menopause: a review with meta-analysis. Menopause. 2019;26(11):1327\u201333.","journal-title":"Menopause"},{"issue":"3","key":"2660_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.numecd.2020.11.026","volume":"31","author":"D He","year":"2021","unstructured":"He D, Fan F, Jia J, Jiang Y, Sun P, Wu Z, et al. Lipid profiles and the risk of new-onset hypertension in a Chinese community-based cohort. Nutr Metabolism Cardiovasc Dis. 2021;31(3):911\u201320.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"2660_CR61","doi-asserted-by":"publisher","first-page":"205031211875666","DOI":"10.1177\/2050312118756663","volume":"6","author":"A Gebrie","year":"2018","unstructured":"Gebrie A, Gnanasekaran N, Menon M, Sisay M, Zegeye A. Evaluation of lipid profiles and hematological parameters in hypertensive patients: laboratory-based cross-sectional study. SAGE Open Med. 2018;6:2050312118756663.","journal-title":"SAGE Open Med"},{"issue":"09","key":"2660_CR62","doi-asserted-by":"publisher","first-page":"132","DOI":"10.53350\/pjmhs22169132","volume":"16","author":"F Farooq","year":"2022","unstructured":"Farooq F, Ali A, Ali A, Nadeem M, Sirhindi GA. Evaluation of lipid profiles and hematological parameters in hypertensive patients. Pakistan J Med Health Sci. 2022;16(09):132.","journal-title":"Pakistan J Med Health Sci"},{"key":"2660_CR63","doi-asserted-by":"crossref","unstructured":"Nakajima K, Igata M, Higuchi R, Tanaka K, Mizusawa K, Nakamura T. Association of serum high-density lipoprotein cholesterol with high blood pressures at checkup: results of Kanagawa investigation of total checkup data from the National Database-9 (KITCHEN-9). J Clin Med. 2021;10(21).","DOI":"10.3390\/jcm10215118"},{"issue":"1","key":"2660_CR64","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/s41598-020-58685-1","volume":"10","author":"M Cherfan","year":"2020","unstructured":"Cherfan M, Vall\u00e9e A, Kab S, Salameh P, Goldberg M, Zins M, et al. Unhealthy behaviors and risk of uncontrolled hypertension among treated individuals-the CONSTANCES population-based study. Sci Rep. 2020;10(1):1925.","journal-title":"Sci Rep"},{"issue":"3","key":"2660_CR65","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/hr.2009.220","volume":"33","author":"R Fogari","year":"2010","unstructured":"Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lazzari P, et al. Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension. Hypertens Res. 2010;33(3):236\u201342.","journal-title":"Hypertens Res"},{"issue":"2","key":"2660_CR66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/2230-8210.93742","volume":"16","author":"JJ Dalal","year":"2012","unstructured":"Dalal JJ, Padmanabhan TN, Jain P, Patil S, Vasnawala H, Gulati A. LIPITENSION: interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab. 2012;16(2):240\u20135.","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2660_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40537-018-0143-6","volume":"5","author":"G Smith","year":"2018","unstructured":"Smith G. Step away from stepwise. J Big Data. 2018;5(1):32.","journal-title":"J Big Data"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02660-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02660-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T04:03:49Z","timestamp":1751861029000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02660-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2660"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02660-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Research Ethics Committees of the Endocrine & Metabolism Research Institute at Tehran University of Medical Sciences approved the study (Reference Code: IR.TUMS.EMRI.REC.1403.071). Participants provided informed consent in person after receiving written information detailing the study\u2019s objectives and procedures in the 2021 STEPS survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used GPT-4 to check grammar. After that, the author reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Usage of AI"}}],"article-number":"232"}}